The DOI matches its Crossref record; 237 of the 238 references it cites were found in a registry or an index.
The isoprostanes—25 years later
Open accessAbstract
Isoprostanes (IsoPs) are prostaglandin-like molecules generated independent of the cyclooxygenase (COX) by the free radical-induced peroxidation of arachidonic acid. The first isoprostane species discovered were isomeric to prostaglandin F2α and were thus termed F2-IsoPs. Since the initial discovery of the F2-IsoPs, IsoPs with differing ring structures have been identified as well as IsoPs from different polyunsaturated fatty acids, including eicosapentaenoic acid and docosahexanenoic acid. The discovery of these molecules in vivo in humans has been a major contribution to the field of lipid oxidation and free radical research over the course of the past 25 years. These molecules have been determined to be both biomarkers and mediators of oxidative stress in numerous disease settings. This review focuses on recent developments in the field with an emphasis on clinical research. Special focus is given to the use of IsoPs as biomarkers in obesity, ischemia-reperfusion injury, the central nervous system, cancer, and genetic disorders. Additionally, attention is paid to diet and lifestyle factors that can affect endogenous levels of IsoPs. This article is part of a Special Issue entitled "Oxygenated metabolism of PUFA: analysis and biological relevance."
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Isoprostanes are specific prostaglandin-like molecules formed by the non-enzymatic ROS-mediated peroxidation of PUFAs, involving for example arachidonic acid (Milne et al. 2015).”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Milne et al. 2015
In the citing paper
“Increased amounts of F2-IsoPs are detected in cardiovascular diseases and other clinical conditions (Milne et al. 2015).”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Milne et al. 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–237 of 237
Clinical Factors Associated with Plasma F2-Isoprostane Levels in HIV-Infected Adults
Redhage, L. A., Shintani, A., Haas, D. W., Emeagwali, N., Marković, M., Oboho, I., Mwenya, C., Erdem, H., Acosta, E. P., Morrow, J. D., et al. (2009) · HIV Clinical Trials · doi:10.1310/hct1003-181 · Cited by 25
Langhorst, M. L., Hastings, M. J., YOKOYAMA, W. H., Hung, S., Cellar, N. A., Kuppannan, K., & Young, S. A. (2010) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf101146q · Cited by 24
Veglia, F., Werba, J. P., Tremoli, E., Squellerio, I., Sisillo, E., Parolari, A., Minardi, F., & Cavalca, V. (2009) · Biomarkers · doi:10.3109/13547500903134395 · Cited by 22
Asombang, A. W., Kayamba, V. J., Lisulo, M. M., Colditz, G. A., Mudenda, V. C., Yarasheski, K. E., Chott, R. C., Rubin, D. C., Gyawali, C. P., Sinkala, E., et al. (2013) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.051284 · Cited by 22
Bastani, N. E., Gundersen, T. E., & Blomhoff, R. (2012) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.6149 · Cited by 21
Clarke, D. L., Belvisi, M. G., Hardaker, E. L., Newton, R. C., & Giembycz, M. A. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.006486 · Cited by 21
Janicka, M., Kubica, P., Kot‐Wasik, A., Kot, J., & Namieśnik, J. (2012) · Journal of Chromatography B · doi:10.1016/j.jchromb.2012.03.005 · Cited by 20
Milne, G. L., Gao, L., Porta, A., Zanoni, G., Vidari, G., & Morrow, J. D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502891200 · Cited by 20
Self-citationIdentification of metabolites from Type III F2-isoprostane diastereoisomers by mass spectrometry
Chiabrando, C., Rivalta, C., Bagnati, R., Valagussa, A., Durand, T., Guy, A., Villa, P., Rossi, J., & Fanelli, R. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30156-5 · Cited by 20
Electrophilic Cyclopentenone Isoprostanes in Neurodegeneration
Musiek, E. S., McLaughlin, B., & Morrow, J. D. (2007) · Journal of Molecular Neuroscience · doi:10.1007/s12031-007-0042-3 · Cited by 19
Weber, T. J., & Markillie, L. M. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.5.1075 · Cited by 19
Ischemia Reperfusion Unveils Impaired Capacity of Older Adults to Restrain Oxidative Insult
Davies, S., Traustadóttir, T., Stock, A. A., Ye, F., Shyr, Y., Harman, S., & Roberts, L. (2009) · Free Radical Biology & Medicine · doi:10.1016/j.freeradbiomed.2009.07.005 · Cited by 19
Self-citationContractile effects of 15-E2t-isoprostane and 15-F2t-isoprostane on chicken embryo ductus arteriosus
van der Sterren, S., & Villamor, E. (2011) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2011.04.010 · Cited by 18
Racial Differences in Urinary F2‐Isoprostane Levels and the Cross‐Sectional Association With bmi
Il’yasova, D., Wang, F. M., Spasojević, I., Baše, K., Agostino, R. B. D., & Wagenknecht, L. E. (2012) · Obesity · doi:10.1038/oby.2012.170 · Cited by 18
Alkazemi, D. U. Z., Egeland, G. M., Roberts, L. J., & Kubow, S. J. (2012) · Free Radical Research · doi:10.3109/10715762.2012.702900 · Cited by 17
Self-citationTsikas, D., & Suchy, M.-T. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.199315 · Cited by 16
Seto, V., Hirota, C. L., Hirota, S. A., & Janssen, L. J. (2007) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0117oc · Cited by 15
Dow, C. A., Wertheim, B. C., Patil, B. S., & Thomson, C. A. (2013) · Journal of Nutrition · doi:10.3945/jn.113.175166 · Cited by 15
Rational Design of Novel Pyridinol-Fused Ring Acetaminophen Analogues
Shchepin, R. V., Liu, W., Yin, H., Zagol-Ikapitte, I. A., Amin, T., Jeong, B., Roberts, L. J., Oates, J. A., Porter, N. A., & Boutaud, O. G. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml4000904 · Cited by 14
Self-citationvan der Sterren, S., Kessels, L. C. G. A., Pérez‐Vizcaíno, F., Cogolludo, A. L., & Villamor, E. (2014) · PubMed · Cited by 13
Higher Serum Iron Is Associated With Increased Oxidant Stress in HIV-Infected Men
Crist, M. B., Melekhin, V. V., Bian, A., Shintani, A., Milne, G. L., Kallianpur, A. R., Dageforde, L. A., Haas, D. W., & Hulgan, T. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3182a60f36 · Cited by 13
Self-citationTaylor, A. W., & Traber, M. G. (2009) · Analytical Biochemistry · doi:10.1016/j.ab.2009.09.042 · Cited by 13
Albers, E. L., Donahue, B. S., Milne, G. L., Saville, B. R., Wang, W., Bichell, D. P., & McLaughlin, B. (2012) · Pediatric Cardiology · doi:10.1007/s00246-012-0166-2 · Cited by 13
Self-citationQuantification of F-Ring and D-/E-Ring Isoprostanes and Neuroprostanes in Alzheimer’s Disease
Reich, E. E., Markesbery, W. R., Roberts, L. J., Swift, L. L., Morrow, J. D., & Montine, T. J. (2001) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0667-6_39 · Cited by 12
Self-citationMas, E., Barden, A. E., Durand, T., Galano, J., Croft, K. D., & Mori, T. A. (2009) · Free Radical Research · doi:10.3109/10715760903390838 · Cited by 12
C-Nociceptor sensitization by isoprostanes is cyclooxygenase dependent
Junger, H., & Sorkin, L. S. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02306-4 · Cited by 12
Revascularization decreases 8-isoprostaglandin F2α excretion in chronic lower limb ischemia
Rossi, P., Riutta, A., Kuukasjärvi, P., Vehmas, T. I., Mucha, I., & Salenius, J. ‐. (2004) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2004.01.003 · Cited by 10
Paredes, C., Tazzeo, T., & Janssen, L. J. (2007) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0022oc · Cited by 10
Enzyme Immunoassay of Isoprostanes
Callewaert, D. M., & Sloan, C. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-029-8_26 · Cited by 10
Zhao, M., Destache, C. J., Ohia, S. E., & Opere, C. A. (2009) · Neurochemical Research · doi:10.1007/s11064-009-0013-x · Cited by 8
Systemic markers of oxidative status and colorectal adenomatous polyps
Siamakpour‐Reihani, S., Scarbrough, P. M., Wang, F. M., Spasojević, I., Baše, K., Sedjo, R. L., D'Agostino, R. B., & Il’yasova, D. (2012) · Annals of Epidemiology · doi:10.1016/j.annepidem.2012.05.001 · Cited by 8
Kaikkonen, J., Vilppo, T., Asikainen, J., Voutilainen, S., Kurl, S., & Salonen, J. T. (2013) · Annals of Medicine · doi:10.3109/07853890.2013.809915 · Cited by 7
Te, L., Oates, J. A., & Roberts, L. J. (1985) · PubMed · Cited by 5
Self-citationReich, E. E., Montine, T. J., & Morrow, J. D. (2002) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0193-0_79 · Cited by 5
[The application of LC-MS/MS in measurement of oxidative stress parameters].
Yin, H., Gao, F., & An, Y. (2009) · PubMed · Cited by 1
- Self-citation
Flagged first, then by citations
1 of the 238 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Dai, 2009, Oxidative stress, obesity, and breast cancer risk: results from the Shanghai Women's health study, J. Clin. Oncol., 27, 2482, 10.1200/JCO.2008.19.7970 · DOI
Cited by
Sorted by citations
Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging
Jomova, K., Raptova, R., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., & Valko, M. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03562-9 · Cited by 2,638
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
Butterfield, D. A., & Halliwell, B. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0132-6 · Cited by 1,954
Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion
Angeli, J. P. F., Krysko, D. V., & Conrad, M. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0149-1 · Cited by 1,275
Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies
Zhou, Q., Meng, Y., Li, D., Yao, L., Le, J., Liu, Y., Sun, Y., Zeng, F., Chen, X., & Deng, G. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01769-5 · Cited by 1,056
Clinical Relevance of Biomarkers of Oxidative Stress
Frijhoff, J., Winyard, P. G., Žarković, N., Davies, S. S., Stocker, R., Cheng, D., Knight, A. R., Taylor, E., Oettrich, J., Ruskovska, T., et al. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6317 · Cited by 918
Metadata
- Authors
- Milne, G. L., Dai, Q., & Roberts, L. J.
- Affiliations
- Vanderbilt University (US)
- Corresponding author
- Roberts, L. Jackson
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Publisher
- Elsevier BV
- Published
- 2015-04
- Volume
- 1851
- Issue
- 4
- Pages
- 433-445
- ISSN
- 1388-1981 (ISSN-L)
- PMC
- PMC5404383
- OpenAlex
- W2059867409
- Cited by
- 335
- References
- 238
- Citations by year
- 2026: 20 · 2025: 20 · 2024: 17 · 2023: 26 · 2022: 30 · 2021: 37 · 2020: 39 · 2019: 37 · 2018: 31 · 2017: 31 · 2016: 34 · 2015: 13
- FWCI
- 2.51
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- GM15431
- ES000267
- CA106591
- Topics
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- isoprostanes, lipid peroxidation, arachidonic acid, free radicals, oxidative stress, biomarkers, F2-isoprostanes, eicosapentaenoic acid, docosahexaenoic acid, obesity, ischemia-reperfusion injury, central nervous system, cancer, genetic disorders, diet and lifestyle, polyunsaturated fatty acids
- MeSH terms
- Animals, Disease, Humans, Structure-Activity Relationship, Lipid Peroxidation, Molecular Structure, Signal Transduction, Biomarkers, Oxidative Stress, Isoprostanes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review